v3.26.1
Segment Information (Tables)
 6 Months Ended
Jun. 30, 2026
Segment Information [Abstract]  
Schedule of Consolidated Net Loss

The following table reflects segment profit or loss, significant expense categories and other segment items regularly provided to the CODM when managing the Company’s reportable segments. A reconciliation to the consolidated net loss for the three and six months ended June 30, 2026 and 2025 is included at the bottom of the tables below.

 

 

    For the Three Months Ended June 30,  
    2026           2025  
    Biotech     Mining     Total     Biotech     Total  
Significant segment expenses                              
General and administrative(1)   $ 78,505     $ 499,437     $ 577,942     $ 729,572     $ 729,572  
Research and development     400,536       -       400,536       238,700       238,700  
Exploration and evaluation     -       561,030       561,030       -       -  
Professional fees     726,341       3,226,093       3,952,434       924,580       924,580  
Interest expense (income)     4,888       -       4,888       1,760,025       1,760,025  
Other segment items     3,463       -       3,463       318,878       318,878  
Total operating and segment expenses   $ 1,213,733     $ 4,286,560     $ 5,500,293     $ 3,971,755     $ 3,971,755  
                                         
Reconciliation of net loss                                        
Change in fair value of warrant liabilities                   $ (1,815,233 )             121,476  
Consolidated net loss                   $ 3,685,060             $ 4,093,231  

 

    For the Six Months Ended June 30,  
    2026           2025  
    Biotech     Mining     Total     Biotech     Total  
Significant segment expenses                              
General and administrative(1)   $ 6,166,587     $ 623,684     $ 6,790,271     $ 1,579,854     $ 1,579,854  
Research and development     721,807       -       721,807       238,700       238,700  
Exploration and evaluation     -       561,030       561,030       -       -  
Professional fees     3,496,522       3,434,601       6,931,123       1,661,266       1,661,266  
Interest expense (income)     6,503       -       6,503       2,313,962       2,313,962  
Impairment expense     2,045,253       -       2,045,253       -       -  
Other segment items     (12,843 )     -       (12,843 )     425,470       425,470  
Total operating and segment expenses   $ 12,423,829     $ 4,619,315     $ 17,043,143     $ 6,219,252     $ 6,219,252  
                                         
Reconciliation of net loss                                        
Change in fair value of warrant liabilities                     499,120               107,961  
Consolidated net loss                   $ 17,542,263             $ 6,327,213  

 

(1) Excludes impairment of licenses and patents; includes share based compensation expense